GMAB
$39.07+1.48%
as of close, Oct 20, 2026
☾ AH $39.07 +1.48%
Genmab A/S ADSStock · Healthcare
Genmab A/S ADS total returns by year (including dividends)
As of market close, Oct 20, 2026
Genmab A/S ADS total returns by year (2010–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $30.80 | $39.07 | 0.0% | +26.9% | |
| 2025 | $20.87 | $30.80 | 0.0% | +47.6% | |
| 2024 | $31.84 | $20.87 | 0.0% | -34.5% | |
| 2023 | $42.38 | $31.84 | 0.0% | -24.9% | |
| 2022 | $39.56 | $42.38 | 0.0% | +7.1% | |
| 2021 | $40.66 | $39.56 | 0.0% | -2.7% | |
| 2020 | $22.33 | $40.66 | 0.0% | +82.1% | |
| 2019 | $16.48 | $22.33 | 0.0% | +35.5% | |
| 2018 | $16.58 | $16.48 | 0.0% | -0.6% | |
| 2017 | $16.58 | $16.58 | 0.0% | -0.0% | |
| 2016 | $13.40 | $16.58 | 0.0% | +23.7% | |
| 2015 | $5.86 | $13.40 | 0.0% | +128.7% | |
| 2014 | $3.91 | $5.86 | 0.0% | +49.7% | |
| 2013 | $1.40 | $3.91 | 0.0% | +179.6% | |
| 2012 | $0.65 | $1.40 | 0.0% | +114.1% | |
| 2011 | $1.35 | $0.65 | 0.0% | -51.6% | |
| 2010 | $1.51 | $1.35 | 0.0% | -10.6% |
- Annualized
- +14.9%
- 2010–2026
- Average year
- +34.0%
- 16 full years
- Best year
- +179.6%
- 2013
- Worst year
- -51.6%
- 2011
- Positive years
- 9/16
- 56% up
Annualized (CAGR)
+14.9%
2010–2026
Average year
+34.0%
16 full years
Best year
+179.6%
2013
Worst year
-51.6%
2011
Positive years
9/16
56% up
Total return by period#
Annual
-100%0%100%
2010-11%'10
2011-52%'11
2012+114%'12
2013+180%'13
2014+50%'14
2015+129%'15
2016+24%'16
2017-0.04%'17
2018-0.61%'18
2019+36%'19
2020+82%'20
2021-2.7%'21
2022+7.1%'22
2023-25%'23
2024-34%'24
2025+48%'25
2026+27%'26
Methodology#
Total returns, dividends reinvested, measured on GMAB. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Genmab A/S ADS's average annual return?
- Since 2010, Genmab A/S ADS (GMAB) has returned about 14.9% a year (the compound annual growth rate) and an average calendar-year return of 34.0%.
- What were Genmab A/S ADS's best and worst years?
- Over 2010–2026, the best year was 2013 (+179.6%) and the worst was 2011 (-51.6%).
- How often is Genmab A/S ADS up in a year?
- 9 of the 16 full years since 2010 were positive — about 56% of the time.
More on Genmab A/S ADS
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100